Podcasts about fidsa

Host Mati Hlatshwayo Davis, MD, MPH, FIDSA is joined by IDSA Senior Vice President of Public Policy and Government Relations Amanda Jezek to discuss the policy challenges shaping infectious diseases, public health and research ahead of the midterm elections. They explore IDSA's advocacy strategy, recent policy wins and how ID professionals can build relationships with policymakers to drive meaningful change.

Paul Sax, MD, FIDSA sits down with comedy-writer, Mike Reiss, and his wife, Denise Reiss, to discuss a lifetime of travel experiences spanning more than 100 countries. From submarine dives and whale sharks to a hospitalization caused by Shigella, they recount remarkable adventures and the health risks that can emerge when exploring the world.

Host Mati Hlatshwayo Davis, MD, MPH, FIDSA, is joined by Darrell McBride, DO, FIDSA, former program director and founder of the Geisinger Ryan White Program, to discuss the realities of delivering HIV and infectious diseases care in rural communities. They explore barriers to care, the role of telehealth and public health partnerships, and what it takes to build sustainable, equity-focused programs in underserved areas.

IDSA CEO Jeanne Marrazzo, MD, MPH, FIDSA, hosts IDSA board members Ronald Nahass, MD, MHCM, FIDSA, Wendy Armstrong, MD, FIDSA, and Max Brito, MD, MPH, FIDSA, to discuss the challenges and opportunities shaping the field of infectious diseases. From defending vaccine science to strengthening the ID workforce and growing membership, the group shares how IDSA is responding to today's health care challenges and preparing for the future.

Host Paul Sax, MD, FIDSA, and guest Rebeca Plank, MD, MPH, return for another Let's Talk ID draft, this time, sharing infectious diseases “love/hates.” They discuss the tools, tests and clinical strategies that inspire both enthusiasm and hesitation in everyday ID practice, and what these mixed feelings reveal about how the field continues to evolve.

Unwanted body habitus changes among people living with HIV receiving antiretroviral therapy (ART) can negatively affect physical and mental health and may even affect ART adherence. Listen to learn from experts Grace A. McComsey, MD, FIDSA, and Richard A. Elion, MD, how to identify people who may be candidates for pharmacologic weight interventions, and hear firsthand from patient advocates how unwanted weight gain impacts their daily life. Topics covered include: The burden of unwanted weight gain among people living with HIV  Potential causes for unwanted weight gain Available pharmacologic agents for weight loss  Clinical trial data supporting pharmacologic agents for weight loss in people living with HIV Patient advocate perspectives Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Diseases Podcast on Apple Podcasts, YouTube Music, or Spotify. Link to full program: https://bit.ly/4cpeJ1I Presenters: Richard A. Elion, MD Clinical Professor of Medicine George Washington University School of Medicine Washington, DC Grace A. McComsey, MD, FIDSA Vice Dean for Clinical and Translational Research Director, Clinical and Translational Science Institute (CTSI) Principal Investigator, Clinical and Translational Science Collaborative (CTSC) of Northern Ohio Gertrude Chandler Tucker Professor of Pediatrics and Medicine Case Western Reserve University Research Integrity Officer Senior Faculty, Pediatric and Adult Infectious Diseases University Hospitals Health System Cleveland, Ohio Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Show Highlights · Dr. James JC Cooley along with Co-Host Dr. Michael Mantell- renowned and esteemed mental health architect and prolific author have a sit-down conversation with Joshua D. Hartzell, MD, MS-HPEd, FACP, FIDSA – Military Veteran, Practicing Internal Medicine, Infectious Diseases Physician, and a Certified Executive Coach · Leadership inspired by caring creates cultures where people can thrive personally and professionally. · Leading from a place of caring is evidence-based leadership · Leading from a place of caring is not soft. · Leading with care can be learned and intentionally implemented. Summary: According to Dr. Joshua Hartzell, caring should be the foundation that drives how we lead others, shaping cultures where individuals can truly thrive both personally and professionally. Leadership rooted in caring is not just an idealistic approach but an evidence-based one, consistently linked to higher engagement, stronger performance, and improved well-being. Far from being “soft,” caring leadership requires courage and discipline, as it involves holding high standards, making tough decisions, and providing honest feedback while maintaining respect and empathy. Importantly, leading with care is not an innate trait reserved for a few—it is a skill that can be learned, practiced, and intentionally implemented through self-awareness, consistent behaviors, and a genuine commitment to valuing people. Joshua D. Hartzell, MD, MS-HPEd, FACP, FIDSA Biography Joshua D. Hartzell, MD, MS-HPEd, FACP, FIDSA is a retired Army Colonel who spent 25 years in military medicine. Dr. Hartzell has held numerous leadership positions throughout his career including being Program Director for the Internal Medicine Residency and Assistant Chief of Graduate Medical Education at Walter Reed National Military Medical Center and Assistant Dean for Faculty Development at the Uniformed Services University. He deployed as a Battalion Surgeon with the 82nd Airborne Division to Afghanistan. Dr. Hartzell is also faculty at the MGH Institute of Health Professions where he teaches leadership development. A practicing Internal Medicine and Infectious Diseases Physician, he has devoted the last decade to developing leaders training and teaching thousands of students, residents, and faculty within healthcare. Dr. Hartzell has delivered over 100 talks on leadership development and has written numerous papers on the topic. Dr. Hartzell is a Certified Executive Coach and holds additional coaching certification in the Leadership Challenge 360. He combined his years of boots on the ground leading in medicine with his research to teach other leaders practical strategies about how to sharpen their leadership skills in his book, A Prescription for Caring in Healthcare Leadership: Building a Culture of Compassion and Excellence. Website: https://joshuahartzellmd.com/ LinkedIn: linkedin.com/in/joshhartzellmdSupport the show: http://www.cooleyfoundation.org/See omnystudio.com/listener for privacy information.

Landing that first job feels like the finish line, but for most young professionals, it is really just the beginning. In this episode, ⁠Xavier Angel⁠, CFP®, ChFC®, CLTC®, sits down with ⁠Christopher Bland⁠, PharmD, FCCP, FIDSA, BCPS, Albert W. Jowdy Professor in Pharmacy Care at the ⁠University of Georgia College of Pharmacy⁠, to unpack the real-world financial questions that pharmacists and other graduates face early in their careers. From understanding compensation packages to negotiating pay, evaluating retirement benefits, and using side income strategically, this conversation helps listeners look beyond the headline salary number and make more informed financial decisions from day one. The episode also dives into one of the biggest mindset shifts young earners need to make: high income does not equal wealth. Chris and Xavier discuss how lifestyle inflation, student debt, and poor planning can quietly eat away at even a strong paycheck, while time, discipline, and consistent investing can build real financial freedom over time. It's a practical, honest conversation designed to help young professionals turn early career income into long-term opportunity. Episode Highlights: Christopher shares the one financial lesson he wished he had fully embraced coming out of school: the more time money has to compound, the more profound the long-term impact. (04:00) Christopher breaks down salary versus hourly pay for new pharmacists, noting how hourly work creates flexibility to earn overtime, shift differentials, and supplemental income. (09:07) Christopher recounts landing his first job at the lowest pay tier and explains why the beginning of a career is the most powerful moment to negotiate compensation. (14:54) Christopher encourages students to lean on faculty and mentors for career opportunities, sharing how he connects students with prospects through his own network. (20:09) Xavier explains the difference between Traditional and Roth 401k contributions and stresses the importance of adding a beneficiary to retirement accounts from day one. (25:52) Christopher uses his son's first paycheck experience to illustrate why new earners need an automated plan for their money from the start. (31:32) Christopher outlines three practical steps for young pharmacists: leverage time for investing, negotiate confidently, and evaluate every aspect of a job beyond salary. (38:26) Key Quotes: “As you are young in your career, be developing skills. Seek out these opportunities, network, because then things will begin to flow to you, especially in years, like three to five.” - Christopher Bland, PharmD, FCCP, FIDSA, BCPS “No matter what degree of money you're making, if you have a plan, you're automatically giving yourself a raise.” - Christopher Bland, PharmD, FCCP, FIDSA, BCPS “I want healthcare professionals, pharmacists, to really take ownership of this topic. We work too hard. You've gone to school for too long, to not have a plan for financial freedom and wealth long term.” - Christopher Bland, PharmD, FCCP, FIDSA, BCPS Resources Mentioned: ⁠Christopher Bland, PharmD, FCCP, FIDSA, BCPS⁠ ⁠University of Georgia College of Pharmacy⁠ ⁠Erik Garcia, CFP®, BFA⁠ ⁠Xavier Angel, CFP®, ChFC, CLTC⁠ ⁠Plan Wisely Wealth Advisors⁠

Landing that first job feels like the finish line, but for most young professionals, it is really just the beginning. In this episode, Xavier Angel, CFP®, ChFC®, CLTC®, sits down with Christopher Bland, PharmD, FCCP, FIDSA, BCPS, Albert W. Jowdy Professor in Pharmacy Care at the University of Georgia College of Pharmacy, to unpack the real-world financial questions that pharmacists and other graduates face early in their careers. From understanding compensation packages to negotiating pay, evaluating retirement benefits, and using side income strategically, this conversation helps listeners look beyond the headline salary number and make more informed financial decisions from day one. The episode also dives into one of the biggest mindset shifts young earners need to make: high income does not equal wealth. Chris and Xavier discuss how lifestyle inflation, student debt, and poor planning can quietly eat away at even a strong paycheck, while time, discipline, and consistent investing can build real financial freedom over time. It's a practical, honest conversation designed to help young professionals turn early career income into long-term opportunity. Episode Highlights: Christopher shares the one financial lesson he wished he had fully embraced coming out of school: the more time money has to compound, the more profound the long-term impact. (04:00) Christopher breaks down salary versus hourly pay for new pharmacists, noting how hourly work creates flexibility to earn overtime, shift differentials, and supplemental income. (09:07) Christopher recounts landing his first job at the lowest pay tier and explains why the beginning of a career is the most powerful moment to negotiate compensation. (14:54) Christopher encourages students to lean on faculty and mentors for career opportunities, sharing how he connects students with prospects through his own network. (20:09) Xavier explains the difference between Traditional and Roth 401k contributions and stresses the importance of adding a beneficiary to retirement accounts from day one. (25:52) Christopher uses his son's first paycheck experience to illustrate why new earners need an automated plan for their money from the start. (31:32) Christopher outlines three practical steps for young pharmacists: leverage time for investing, negotiate confidently, and evaluate every aspect of a job beyond salary. (38:26) Key Quotes: “As you are young in your career, be developing skills. Seek out these opportunities, network, because then things will begin to flow to you, especially in years, like three to five.” - Christopher Bland, PharmD, FCCP, FIDSA, BCPS “No matter what degree of money you're making, if you have a plan, you're automatically giving yourself a raise.” - Christopher Bland, PharmD, FCCP, FIDSA, BCPS “I want healthcare professionals, pharmacists, to really take ownership of this topic. We work too hard. You've gone to school for too long, to not have a plan for financial freedom and wealth long term.” - Christopher Bland, PharmD, FCCP, FIDSA, BCPS Resources Mentioned: Christopher Bland, PharmD, FCCP, FIDSA, BCPS University of Georgia College of Pharmacy Erik Garcia, CFP®, BFA Xavier Angel, CFP®, ChFC, CLTC Plan Wisely Wealth Advisors

Cytomegalovirus (CMV) infection is one of the most significant infectious complications after hematopoietic cell transplant (HCT), but there have been major advances in CMV management to date. In this podcast, featuring curated audio from a live satellite symposium, experts Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID, and Marcus Pereira, MD, MPH, FAST, discuss considerations for CMV treatment in HCT recipients and examine treatment options for refractory/resistant CMV. Topics include: Considerations for CMV management in HCT recipients New definitions of refractory and resistant CMV  Risk factors for refractory and resistant CMV infections Identifying drug-resistant CMV  Treatment options for refractory/resistant CMV To view the full educational program and download the accompanying slides, visit our website:https://bit.ly/4lfrDTT Presenters: Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID Professor and Chair G.P. Bodey, Sr. Distinguished Professorship in Infectious Diseases President, The International Immunocompromised Host Society (ICHS) Director, Clinical Virology Research Department of ID/IC/EH UT MD Anderson Cancer Center Houston, Texas Marcus Pereira, MD, MPH, FAST Associate Professor of Medicine Director of Clinical Services, Division of Infectious Diseases Medical Director, Transplant Infectious Disease Program Columbia University Irving Medical Center New York, New York Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Cytomegalovirus (CMV) infection is one of the most significant infectious complications after hematopoietic cell transplant (HCT). In this podcast, featuring curated audio from a live satellite symposium, experts Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID and Marcus Pereira, MD, MPH, FAST, discuss the burden of CMV in HCT recipients and explore strategies effectively identify and monitor high-risk patients. Topics include: Epidemiology of CMV among HCT recipients Direct and indirect effects of CMV after HCT Dynamics of risk factors for CMV infection  Strategies for prevention of CMV infection To view the full educational program and download the accompanying slides, visit our website:https://bit.ly/4lfrDTT Presenters: Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID Professor and Chair G.P. Bodey, Sr. Distinguished Professorship in Infectious Diseases President, The International Immunocompromised Host Society (ICHS) Director, Clinical Virology Research Department of ID/IC/EH UT MD Anderson Cancer Center Houston, Texas Marcus Pereira, MD, MPH, FAST Associate Professor of Medicine Director of Clinical Services, Division of Infectious Diseases Medical Director, Transplant Infectious Disease Program Columbia University Irving Medical Center New York, New York Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Welcome to Transmission Interrupted! In this episode, host Jill Morgan sits down with the principal investigators of NETEC—Dr. Aneesh Mehta, Dr. Vikramjit Mukherjee, and Dr. John Lowe—to reflect on a decade of advancing special pathogen preparedness across the U.S. healthcare system. Together, they revisit the origins of NETEC, tracing back to the transformative events of the 2014 Ebola outbreak, and share their unique journeys as infectious disease experts, critical care clinicians, and scientists on the front lines. The conversation dives into the challenges and lessons learned while building a national network equipped for high-consequence infectious diseases, the evolution from isolated specialty units to a system-wide approach, and the critical importance of healthcare worker safety. You'll hear insights on what it takes to maintain readiness in a landscape of ever-changing threats, the value of interdisciplinary collaboration, and a call to expand this “tight-knit club” of preparedness champions. Whether you're a healthcare professional, public health advocate, or just curious about how the U.S. prepares for medical crises, this episode delivers an inspiring look at the past, present, and future of special pathogen response—and why it matters to us all. Guests John-Martin Lowe, PhD John-Martin Lowe, PhD, is the director of the Global Center for Health Security, assistant vice chancellor for health security training and education, and professor of Environmental, Agricultural and Occupational Health at the University of Nebraska Medical Center. At the University of Nebraska Medical Center, he leads research and training initiatives to advance environmental risk assessment and infection control for high consequence pathogens. As a virologist and environmental exposure scientist, Dr. Lowe has worked extensively throughout the U.S., Africa, Asia and Europe as an educator, researcher, and in health emergency risk management related to infectious disease, infection control and emergency response. As a professor of environmental and occupational health, his expertise focuses on infectious disease risk assessment and management of risk for clinical, community and industrial environments. Dr. Lowe also has extensive experience in emerging pathogens and health security. He is co-PI for the U.S. National Emerging Special Pathogens Training and Education Center, established an international network for emerging infectious diseases, and served lead investigator for a multi-country bio-surveillance network in Africa. He has experience in a broad range of health security topics from surveillance, public health response and clinical response to health emergencies. Dr. Lowe led successful COVID-19 efforts in 2020 at the National Quarantine Unit and Nebraska Biocontainment Unit to provide monitoring and care for repatriated U.S. citizens exposed to and infected with SARS Coronavirus 2. He also led early and continued efforts to characterize the transmission dynamics of SARS Coronavirus 2 which were presented to in a joint meeting hosted by the Academy of Medicine and American Public Health Association on April 15, 2020. Dr. Aneesh Mehta, MD, FIDSA, FAST Aneesh Mehta is a Professor of Medicine and of Surgery at Emory University School of Medicine, and also serves as the Chief of Infectious Diseases Services and Assistant Director of Transplant Infectious Diseases at Emory University Hospital. He is a board-certified infectious diseases physician, who received an MD from the University of Oklahoma and completed Internal Medicine and Infectious Diseases training at Emory University. Aneesh has been one of the core physicians of the Emory Serious Communicable Diseases Unit (SCDU) since 2009. He was admitted physician for Emory's first patient with Ebola Virus Disease and was highly involved in care of the four patients with EVD, one patient with Lassa Fever, and several PUIs cared for by the Emory SCDU. During the Ebola activation, Aneesh was involved in all aspects of unit management, patient care, laboratory handling, and research. Aneesh is a co-Principal Investigator at NETEC. He also has been involved in development of the Special Pathogens Research Network Biorepository and evaluation of Medical Countermeasures. Vikramjit Mukherjee, MD, FRCP (Edin) Vikramjit Mukherjee is an intensive care physician who serves as the Chief of Critical Care at NYC Health+Hospitals/Bellevue. He also is the Chief of Bellevue's Special Pathogens Program. Dr. Mukherjee is an Associate Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at the NYU Grossman School of Medicine. Dr. Mukherjee serves as co-Principal Investigator for NETEC, as a steering committee member for the National Special Pathogens System of Care, and as an executive member of the Task Force for Mass Critical Care. His research interests include special pathogen preparedness and mass critical care. Vikramjit Mukherjee completed his medical training at Armed Forces Medical College, India, before arriving in the United States. Here, he completed his residency and chief residency at Georgetown University/Washington Hospital Center and fellowship and chief fellowship in Pulmonary and Critical Care Medicine at New York University Medical Center. Following completion of training in 2015, he joined faculty in the Division of Pulmonary, Critical Care and Sleep Medicine at New York University Grossman School of Medicine. Host Jill Morgan, RN Emory Healthcare, Atlanta, GA Jill Morgan is a registered nurse and a subject matter expert in personal protective equipment (PPE) for NETEC. For 35 years, Jill has been an emergency department and critical care nurse, and now splits her time between education for NETEC and clinical research, most of it centering around infection prevention and personal protective equipment. She is a member of the Association for Professionals in Infection Control and Epidemiology (APIC), ASTM International, and the Association for the Advancement of Medical Instrumentation (AAMI). Resources About NETECNETEC LeadershipTransmission Interrupted PodcastNational Special Pathogen System (NSPS)NETEC Resource Library About NETEC A Partnership for Preparedness The National Emerging Special Pathogens Training and Education Center's mission is to set the gold standard for special pathogen preparedness and response across health systems in the U.S. with the goals of driving best practices, closing knowledge gaps, and developing innovative resources. Our vision is a sustainable infrastructure and culture of readiness for managing suspected and confirmed special pathogen incidents across the United States public health and health care delivery systems. For more information visit NETEC on the web at www.netec.org. NETEC Consultation Services Assess and Advance Your Readiness for Special Pathogens with Free, Expert Consulting. NETEC offers free virtual and onsite readiness consulting to help health care facilities and EMS agencies prepare for special pathogen events. Our targeted support services are delivered by experts selected and assigned to each inquiry based on the unique needs of your organization. Have a question? Ask a NETEC expert. For more information visit: netec.org/consulting-services.

Paul Sax, MD, FIDSA, sits down with Patrick Passarelli, MD, a med-peds ID physician at Dartmouth-Hitchcock and ID editor for theMednet, to explore how clinicians can get expert guidance beyond AI. They dive into the origins of theMednet, what makes a great clinical question, and how this growing community of medical experts is shaping practice.

In a special encore presentation in honor of Black History Month, Let's Talk ID host and IDSA Board member Mati Hlatshwayo Davis, MD, MPH, FIDSA, speaks with HIVMA Chair Allison Agwu, MD, ScM, FIDSA, HIVMA Immediate Past Chair Michelle Cespedes, MD, MS, and Darrell McBride, DO, about their experiences as Black infectious diseases physicians.

Stacey Rubin Rose, MD, FACP, FIDSA, makes her memorable Faculty Factory Podcast debut this week with an overview of strategies for autonomy-supportive teaching. Dr. Rose is an Associate Professor in the Department of Medicine (Infectious Diseases). She is also an Associate Professor in the Huffington Department of Education, Innovation, and Technology and the Associate Director of the Center for Professionalism at Baylor College of Medicine in Houston. “The goal of this faculty development for autonomy-supportive teaching is to help faculty create better learning environments for trainees and for themselves,” Dr. Rose said. “When you can foster a supportive learning environment, everyone benefits and you see far less burnout,” Dr. Rose added in the opening moments of the interview. Another goal of this educational push and the faculty development workshop mentioned in this episode is to connect self-determination theory with medical well-being and medical education. For a refresher on self-determination theory, you can revisit Faculty Factory Episode No. 69, “Self-Determination Theory in Academic Medicine with Jeffrey M. Lyness, MD, FACPsych”: https://facultyfactory.org/self-determination-theory-in-academic-medicine/ “If you can teach and educate in a clinical learning environment that is supportive of autonomy, belonging, and competence—with autonomy as the anchor—then everyone wins,” she said. As also mentioned in this episode, if you want to hear more about Baylor's Center for Professionalism you can listen to Faculty Factory Episode No. 359, “Promoting Positive Professionalism with Ellen M. Friedman, MD, FACS, FAAP”: https://facultyfactory.org/ellen-friedman/

The United States has left the World Health Organization, and we have entered a new anti-science era. What does that mean for the well-being of people in the United States and around the world? Are alternative structures being put in place? Does it help when states take their own measures? What can we do to keep our families and communities safe? Dr. Tyler Evans, MD, MS, MPH, DTM&H, FIDSA is an infectious diseases and addiction medicine public health physician associate professor and humanitarian. He is the author of Poverty, Pandemics and Politics and the CEO of Wellness Equity.https://www.wellnessequityalliance.com/ https://www.instagram.com/diprimaradio/

This week on the Faculty Factory Podcast, author Joshua Hartzell, MD, MS-HPEd, FACP, FIDSA, is back on the show, and we're taking a deep dive into feedback. We discuss how to give and receive feedback more effectively—a topic that we all should strive to improve in our professional lives. With 25 years of experience in military medicine, Dr. Hartzell is a retired army colonel as well as a practicing internist and infectious diseases physician. Feedback is meant to be a conversation, helping each other better understand where the other individual is coming from. After all, we're never sure what is going on in someone's life until we ask. How do we get better at feedback? Yes, you can read books and consume podcasts like this on it, but explicitly asking someone to give you feedback about yourself may be an even stronger starting point. Dr. Hartzell also encourages getting feedback on your feedback, as it takes practice. "When we give people feedback, it tells them whether their performance aligns with our expectations or not; it really clarifies our expectations. I think that's really important because, without that, it's sort of left up to people to decide: 'Am I doing a good job?'" he told us. Another crucial element surrounding this interview is the critically important notion that a lack of feedback is still a form of feedback so there are no doubt consequences of choosing silence and inaction. Explore Resources from this Podcast Dr. Hartzell's first appearance on our Faculty Factory Podcast, titled “A Comprehensive Look at Developing Excellent Leadership in Medicine” can be found here:  https://facultyfactory.org/joshua-hartzell/ You can learn more about Dr. Hartzell's book, “A Prescription for Caring in Healthcare Leadership: Building a Culture of Compassion and Excellence”, here: https://www.amazon.com/Prescription-Caring-Healthcare-Leadership-Compassion/dp/B0DSQ4276K   Disclaimer: The opinions and assertions expressed herein are those of the author and do not reflect the official policy or position of the Army, Navy, Air Force, the Uniformed Services University of the Health Sciences or the Department of War. References: Kim Scott, Radical Candor: Be a Kick-Ass Boss Without Losing Your Humanity (New York: St. Martin's Press, 2019).  Ende J. Feedback in clinical medical education. JAMA. 1983 Aug 12;250(6):777-81.

Listen to this podcast featuring highlights from our expert roundtable discussion to learn about the most pressing issues in pediatric influenza vaccines, including current vaccine technologies, recent vaccine uptake and epidemiologic trends, and how to discuss the vast benefits of timely vaccination in pediatric patients with their parents and caregivers. Topics covered include:Groups at High Risk for ComplicationsGuideline Recommendations for Influenza VaccinationAvailable Seasonal Flu Vaccine Formulations and Their CharacteristicsPractical Considerations for Selecting Pediatric Influenza VaccinesUptake of Influenza Vaccines in Children: Reversing the TrendsPresenters:Ravi Jhaveri, MD, FIDSA, FPIDS, FAAPDivision HeadPediatric Infectious DiseasesAnn & Robert H. Lurie Children's Hospital of ChicagoProfessor of PediatricsNorthwestern University Feinberg School of MedicineChicago, IllinoisTina Q. Tan, MD, FAAP, FIDSA, FPIDSProfessor of PediatricsFeinberg School of Medicine of Northwestern UniversityPediatric Infectious Diseases AttendingMedical Director, International Adoptee ClinicPresident, Lurie Medical/Dental StaffAnn & Robert H. Lurie Children's Hospital of ChicagoChicago, IllinoisJennifer M. Walsh, DNP, CPNP-PC, CNECertified Pediatric Nurse Practitioner, Primary CareAssistant ProfessorGeorge Washington UniversitySchool of NursingWashington, DCLink to full program: https://bit.ly/45UVzy6Get access to all of our new episodes by subscribing to the Decera Clinical Education Infectious Diseases Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Can a simple nasal antiseptic protect ICU patients from deadly MRSA infections? This episode dives into how a Michigan hospital team reduced bloodstream infections with a twice-daily antiseptic, why it worked, and what it takes to implement this approach. With expert insights and real-world challenges, this is prevention in action, right under your nose. With special guests: Sarah Prascius, MPH, CIC, Infection Prevention Specialist, Henry Ford West Bloomfield Hospital - Michigan Alex Wells, MPH, CIC, CPHQ, Manager of Safety and Reliability, Henry Ford West Bloomfield Hospital - Michigan Tricia Stein, MD, FIDSA, FACP, Medical Director of Infection Prevention and Antimicrobial Stewardship and Chief of the Infectious Disease Section, Henry Ford West Bloomfield Hospital - Michigan

Paul Sax, MD, FIDSA, sits down with infectious disease and critical care physician, Matthew Brigmon, MD, of the University of Texas at San Antonio, to explore his unique path as a double-boarded physician. They discuss the challenges and rewards of combining the two specialties and share guidance for trainees interested in forging a career in ID Critical Care.This holiday season, you can help strengthen the infectious diseases workforce and support the people who advance patient care and public health every day. All donations to the IDSA Foundation through December 31 are matched up to $50,000. Learn more and double your impact at idsafoundation.org. 

Listen in as experts Thomas P. Lodise, PharmD, PhD, and George Sakoulas, MD, FIDSA, explore tailored antibiotic strategies for diverse patients with acute bacterial skin and skin structure infections (ABSSSIs). Their insightful discussion focuses on antibiotic developments that followed publication of the IDSA practice guidelines in 2014 and the challenges unique to ABSSSIs, including a lack of determined bacterial etiology for many cases. PresentersThomas P. Lodise, PharmD, PhDProfessorAlbany College of Pharmacy and Health SciencesInfectious Diseases Clinical Pharmacy SpecialistStratton VA Medical CenterAlbany, New YorkGeorge Sakoulas, MD, FIDSAChief, Infectious DiseasesSharp Rees-Stealy Medical GroupAdjunct Professor of PediatricsUniversity of California San Diego School of MedicineSan Diego, CaliforniaLink to full program:https://bit.ly/4oIKwzsGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Host Mati Hlatshwayo Davis, MD, MPH, FIDSA, and former CDC director Demetre Daskalakis MD, MPH, explore the current state of public health. They discuss how political pressures and weakened infrastructure have left the system vulnerable, and how this moment could spark a public health “renaissance."

Fear of virologic failure is a major barrier to ensuring that people living with virally suppressed HIV are receiving the most optimal antiretroviral therapy (ART) regimen for them. Stream this Medical Minute to learn more about key guideline recommendations regarding ART switch and reassuring clinical data regarding efficacy, tolerability, and quality of life associated with switching a suppressive ART regimen. Topics covered include:Efficacy of switching to 2-drug oral ART: real-world evidenceReal-world analyses of virologic failure with switch to long-acting cabotegravir plus rilpivirinePatient selection to reduce risk of virologic failure with switch Regimen-specific switch considerationsPresenters:Dima Dandachi, MD, MPH, FIDSA, FACPAssociate Professor of MedicineDivision of Infectious DiseasesUniversity of MissouriMedical DirectorHIV Treatment and Prevention Program, MUHCMedical DirectorBoone County Public Health and Human ServicesColumbia, MissouriChloe Orkin, MBChB, FRCP, MDProfessor of Infection and InequitiesDean for Healthcare TransformationQueen Mary University of LondonFaculty of Medicine and DentistryHonorary Consultant PhysicianBarts Health NHS TrustLondon, United KingdomLink to full program and accompanying slides:https://bit.ly/3KPN0xbGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Sepsis and bloodstream infections (BSIs) are common and cause millions of deaths each year, with a disproportionate burden in low-income and middle-income countries. Tune in to learn from Jasmine R. Marcelin, MD, FACP, FIDSA, how inadequate antibiotic coverage can be linked to increased mortality and length of stay and how unnecessary broad-spectrum antibiotics can drive antimicrobial resistance. Topics covered include:The worldwide burden of sepsis and BSIsThe ongoing threat of antimicrobial resistanceUS and global health disparities in sepsis, BSI, and antimicrobial resistanceBarriers toward optimizing antibiotic use in BSIsPresenter:Jasmine R. Marcelin, MD, FACP, FIDSAAssociate Professor, Infectious DiseaseAssociate Medical Director, Antimicrobial Stewardship ProgramVice Chair for Belonging and Community Engagement, Department of Internal MedicineCo-Director, Digital Innovation & Social Media Strategy, Division of Infectious DiseasesUniversity of Nebraska Medical CenterOmaha, NebraskaLink to full program and downloadable slides:https://bit.ly/4inoXCxGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Overview: In this episode, Dr Melissa Jones and Dr Christian Ramers discuss the importance of pan-viral screening for HIV and hepatitis. They emphasize the need for integrated testing and prevention strategies and the current barriers to implementation. The views expressed are those of the panelist(s) and not necessarily Gilead Sciences, Inc. The information provided in this podcast is not intended to be and should not be understood to provide medical advice. Listeners should note that our discussions in this episode are relevant to the USA only and may not be appropriate for other regions. This episode was recorded in August 2025 and the content reflects the information available at that time. Guest: Christian B Ramers, MD, MPH, FIDSA, AAHIVS; Melissa Jones, DNP, APRN-BC   For more information, please visit: https://www.pri-med.com/clinical-resources/curriculum/hiv-in-focus  References AASLD/IDSA. HCV guidance: recommendations for testing, managing, and treating hepatitis C. 2025. Available from: https://www.hcvguidelines.org/ (Accessed June 10, 2025). Arora DR et al. ISRN AIDS 2013;2013:287269 Alter MJ. J Hepatol 2006;44:S6–9. Bazargan M, Cobb BMS, Assari S. Ann Fam Med 2021;19:4–15. Beard N, Hill A. Open Forum Infect Dis 2024;11:ofad666. Bottero J, Boyd A, Gozlan J et al. Open Forum Infect Dis 2015;2:ofv162. Brunetto, Maurizia Rossana et al. J Hepatol 2023;79:433–60. Calabrese SK, Krakower DS, Mayer KH. Am J Public Health 2017;107:1883–89. CDC. Status neutral HIV care and service delivery eliminating stigma and reducing health disparities. 2022. Available from: https://stacks.cdc.gov/view/cdc/129024 (Accessed June 10, 2025). CDC. Clinical guidance for PrEP. 2025. Available from: https://www.cdc.gov/hivnexus/hcp/prep/index.html (Accessed June 10, 2025). CDC. Clinical screening and diagnosis for hepatitis C. 2025. Available from: https://www.cdc.gov/hepatitis-c/hcp/diagnosis-testing (Accessed June 10, 2025). CDC. Clinical testing and diagnosis for hepatitis B. 2025. Available from: https://www.cdc.gov/hepatitis-b/hcp/diagnosis-testing/  (Accessed June 10, 2025). CDC. Clinical testing guidance for HIV. 2025. Available from: https://www.cdc.gov/hivnexus/hcp/diagnosis-testing/index.html (Accessed June 10, 2025). CDC. Getting tested for HIV. 2025. Available from: https://www.cdc.gov/hiv/testing/ (Accessed June 10, 2025). CDC. Hepatitis A vaccine. 2025. Available from: https://www.cdc.gov/hepatitis-a/vaccination/index.html (Accessed June 10, 2025). CDC. Hepatitis B vaccine. 2025. Available from: https://www.cdc.gov/hepatitis-b/vaccination/index.html (Accessed June 10, 2025). CDC. HIV infection among heterosexuals at increased risk--United States, 2010. MMWR Morb Mortal Wkly Rep 2013;62:183-8. CDC. Viral hepatitis among people with HIV. 2025. Available from: https://www.cdc.gov/hepatitis/hcp/populations-settings/hiv.html (Accessed June 10, 2025. Clinical info HIV.gov. Considerations for Antiretroviral Use in People With Coinfections, Hepatitis B Virus/HIV Coinfection. 2024. Available from: https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/hepatitis-b-virus-hiv-coinfection (Accessed July 21, 2025). Cornberg M, Sandmann L, Jaroszewicz J et al. J Hepatol 2025; doi: 10.1016/j.jhep.2025.03.018. Coukan F, Murray KK, Papageorgiou V et al. HIV Med 2023;24:893–913. DHHS. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. 2024. Available from: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-arv/guidelines-adult-adolescent-arv.pdf (Accessed June 25, 2025). GHTF. Breaking the silence: combating stigma and misinformation in the fight against hepatitis. 2024. Available from: https://www.globalhep.org/news-blogs/breaking-silence-combating-stigma-and-misinformation-fight-against-hepatitis (Accessed June 10, 2025) Grieb SM, Harris R, Rosecrans A et al. Ann Med 2022;54:138–49. HIV.gov. US statistics. 2025. Available from: https://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics (Accessed June 10, 2025). Kitt H et al. HIV testing, PrEP, new HIV diagnoses and care outcomes for people accessing HIV services: 2024 report. 2024. Available from https://www.gov.uk/government/statistics/hiv-annual-data-tables/hiv-testing-prep-new-hiv-diagnoses-and-care-outcomes-for-people-accessing-hiv-services-2024-report (Accessed June 10, 2025) Mayer KH, Agwu A, Malebranche D. Adv Ther 2020;37:1778–811. Mohareb AM, Larmarange J, Kim AY et al. Lancet HIV 2022;9:e585–e94. Moorman AC, Bixler D, Teshale EH et al. Public Health Rep 2023; doi: 10.1177/00333549231181348 Orkin, C. Open Forum Infect Dis 2024;11:ofad668. Post Z et al. Clin Liver Dis 2023;27:973-84 Saleska JL, Lee SJ. JAMA Pediatr 2020;174:1133–34. Symum H, Van Handel M, Sandul A et al. Prev Med Rep 2024;44:102777. UNAIDS. Global HIV & AIDS statistics — Fact sheet. 2025. Available from: https://www.unaids.org/en/resources/fact-sheet (Accessed July 18, 2025). UNM. Project ECHO. 2025. Available from: https://projectecho.unm.edu/ (Accessed June 10, 2025). Wejnert C et al. MMWR Morb Mortal Wkly Rep. 2016;65:1336–1342 WHO. Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations (Geneva). 2022. Available from: https://www.who.int/publications/i/item/9789240052390 (Accessed June 10, 2025). WHO. Fact sheet: hepatitis A. 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-a (Accessed June 10, 2025). WHO. Fact sheet: hepatitis B. 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b (Accessed July 18, 2025). WHO. Fact sheet: hepatitis D. 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-d (Accessed June 10, 2025). WHO. Guidelines on HIV self-testing and partner notification: a supplement to the consolidated guidelines on HIV testing services. 2016. Available from: https://iris.who.int/handle/10665/251655 (Accessed June 10, 2025). WHO. Recommendations and guidance on hepatitis C virus self-testing. 2021. Available from: https://www.who.int/publications/i/item/9789240031128 (Accessed June 10, 2025). Xiao Y et al. Cells. 2020;9:2233

Overview: In this episode, Toyin Nwafor, MD, and Christian B Ramers, MD, draw on their experience in primary care, HIV and HIV prevention to highlight missed opportunities for HIV prevention and discuss strategies to help address gaps in the HIV care continuum. The views expressed are those of the panelist(s) and not necessarily Gilead Sciences, Inc. The information provided in this podcast is not intended to be and should not be understood to provide medical advice. Listeners should note that our discussions in this episode are relevant to the USA only and may not be appropriate for other regions. This episode was recorded in August 2025 and the content reflects the information available at that time. Guest: Toyin Nwafor, MD; Christian B Ramers, MD, MPH, FIDSA, AAHIVS   For more information, please visit: https://www.pri-med.com/clinical-resources/curriculum/hiv-in-focus  References AIDSVu.org. Prevalence in the United States. 2022. Available from: https://map.aidsvu.org/ (Accessed June 25, 2025). AIDSVu.org was developed by the Rollins School of Public Health at Emory University in partnership with Gilead Sciences, Inc. Baeten J et al. Curr HIV/AIDS Rep 2013;10:142–51. CDC. Clinical testing guidance for HIV. 2025. Available from: https://www.cdc.gov/hivnexus/hcp/diagnosis-testing/index.html (Accessed June 25, 2025). CDC. Discussing sexual health with your patients. 2025. Available from: https://www.cdc.gov/hivnexus/hcp/sexual-history/index.html (Accessed June 25, 2025). CDC.gov. HIV diagnoses, deaths, and prevalence. 2025. Available from: https://www.cdc.gov/hiv-data/nhss/hiv-diagnoses-deaths-prevalence.html (Accessed June 25, 2025). CDC. National HIV prevention and care objectives: 2025 update. 2025. Available from: https://www.cdc.gov/hiv-data/nhss/national-hiv-prevention-and-care-objectives-2025.html (Accessed June 25, 2025). CDC. Preexposure prophylaxis for the prevention of HIV infection in the United States – 2021 update: a clinical practice guideline. 2021. Available from: https://stacks.cdc.gov/view/cdc/112360 (Accessed June 25, 2025). Doblecki-Lewis S et al. J Int Assoc Provid AIDS Care 2019;18:2325958219848848. DHHS. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. 2024. Available from: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-arv/guidelines-adult-adolescent-arv.pdf (Accessed June 25, 2025). HIV.gov. Key EHE strategies. 2024. Available from: https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/key-strategies (Accessed June 2, 2025). HIV.gov. HIV treatment as prevention. 2023. Available from: https://www.hiv.gov/tasp (Accessed June 25, 2025). HIV.gov. US statistics. 2025. Available from: https://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics (Accessed May 21, 2025). HIV.gov. Viral suppression and undetectable viral load. 2025. Available from: https://www.hiv.gov/hiv-basics/staying-in-hiv-care/hiv-treatment/viral-suppression (Accessed July 18, 2025). HIV.gov. Who is at risk for HIV. 2025. Available from: https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/who-is-at-risk-for-hiv (Accessed June 25, 2025). Johns Hopkins Bloomberg School of Public Health. What to know about PrEP. 2025. Available from: https://publichealth.jhu.edu/2025/who-needs-prep-for-hiv-prevention (Accessed June 25, 2025). Kamis KF et al. Open Forum Infect Dis 2019;6:ofz310. KFF. HIV testing in the United States. 2024. Available from: https://www.kff.org/hiv-aids/hiv-testing-in-the-united-states/ting in the United States | KFF (Accessed August 26, 2025). NIH. HIV and sexually transmitted infections (STIs). 2021. Available from: https://hivinfo.nih.gov/understanding-hiv/fact-sheets/hiv-and-sexually-transmitted-infections-stis (Accessed June 25, 2025). Ramchandani MS et al. Curr HIV/AIDS Rep 2019;16:244–56. Saag MS et al. JAMA 2018;320:379–96. Sweeney P et al. J Acquir Immune Defic Syndr 2019;82(Suppl 1):S1–5. The White House. National HIV/AIDS strategy for the United States 2022–2025. 2021. Available from: https://files.hiv.gov/s3fs-public/NHAS-2022-2025.pdf (Accessed June 25, 2025). UNAIDS.org. Recommended 2030 targets for HIV. 2025. Available from: https://www.unaids.org/en/recommended-2030-targets-for-hiv (Accessed August 26, 2025). United States Census Bureau. National population by characteristics: 2020-2024. 2024. Available from: https://www.census.gov/data/tables/time-series/demo/popest/2020s-national-detail.html (Accessed June 25, 2025). United States Census Bureau. United States Population Growth by Region. 2025. Available from: https://www.census.gov/popclock/ (Accessed June 25, 2025). Yumori C et al. Sex Transm Dis 2021;48:32–6.

Let's Talk ID hosts, Buddy Creech, MD, MPH, FPIDS, Mati Hlatshwayo Davis, MD, MPH, FIDSA and Paul Sax, MD, FIDSA reunite live at IDWeek 2025 to share their hottest takes on infectious diseases and public health. They discuss the controversial dismantling of CDC, exciting breakthroughs in treating staph aureus bacteremia, and shifts that could shape the future of the field.

Lekshmi Santhosh, MD, MAEd, an innovative leader in medicine, joins our Faculty Factory Podcast this week to discuss building an array of mentors, each playing a different role in your life and career journey in academic medicine. She also encourages us to challenge conventional definitions of mentoring throughout this conversation. The concept of matrix mentorship invites us to explore the metaphor of a “bouquet of mentors,” which is a central theme of the interview. At the University of California, San Francisco (UCSF), Dr. Santhosh is an Associate Professor of Pulmonary/Critical Care Medicine and Hospital Medicine. She serves as the Department of Medicine's Associate Chair for Mentorship and People Development and is the Associate Program Director for the internal medicine residency program at UCSF. She also holds the title of Gold-headed Cane Endowed Education Chair in Internal Medicine. Her passion for mentoring trainees, early-career faculty, and peers shines throughout this discussion. “Just knowing that one mentor is not going to be able to meet all your needs is really important,” Dr. Santhosh emphasizes. Thank you to a dear friend of the Faculty Factory, Joshua Hartzell, MD, MS-HPEd, FACP, FIDSA, for recommending Dr. Santhosh as a guest on our show. It was a very memorable and special debut on the Faculty Factory Podcast for her. You can revisit our leadership conversation with Dr. Hartzell: https://facultyfactory.org/joshua-hartzell/ And of course, if you have a guest you'd like us to invite for a conversation on our podcast, please send us a message: https://facultyfactory.org/contact-us/

Ana Velez, MD, FACP, joins Paul Sax, MD, FIDSA, to share how her passion for art fuels her work in infectious diseases, from teaching through medical illustrations to using her art to give back to the ID community. Dr. Velez reveals the inspirations behind her work and how creativity brings new meaning to medicine. She also discusses her latest series of paintings that she is donating to the IDSA Foundation's Art Auction.Bid now to own one of Dr. Velez's paintings: https://givebutter.com/c/pclXSb/auctionShape the future of ID with peers from around the world this October at IDWeek in Atlanta, Georgia! Register today ➡️ https://registration.experientevent.com/ShowIDS251View the interactive program ➡️ https://idweek2025.eventscribe.net/

In this podcast, expert faculty Atul Humar, MD, FRCP (C), and Camille Kotton, MD, FIDSA, FAST, take a deep dive into complex clinical scenarios and explore designing antiviral regimens for refractory CMV infections to minimize antiviral toxicities and maximize efficacy. Topics covered include:Management for suspected drug-resistant CMV infection Illustrative patient cases Gene mutations in CMV  Presenters:Atul Humar, MD, FRCPC, FASTProfessorDepartment of MedicineUniversity of TorontoEaton Family Chair in Transplant Infectious DiseasesAjmera Transplant CentreUniversity Health NetworkToronto, CanadaCamille Kotton, MD, FIDSA, FAST Clinical Director, Transplant and Immunocompromised Host Infectious DiseasesInfectious Diseases DivisionMass General Brigham Endowed Cancer Chair IVMassachusetts General HospitalAssociate Professor, Harvard Medical SchoolBoston, MassachusettsLink to full program:https://bit.ly/4lOa2kAGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Tune in to learn the fundamentals for timely identification of refractory cytomegalovirus (CMV) infections following solid organ transplantation from expert faculty, Camille Kotton, MD, FIDSA, FAST. Topics covered include:Direct and indirect effects of CMV infectionRisk factors for resistant/refractory CMVDefining resistant/refractory CMVPresenter:Camille Kotton, MD, FIDSA, FAST Clinical Director, Transplant and Immunocompromised Host Infectious DiseasesInfectious Diseases DivisionMass General Brigham Endowed Cancer Chair IVMassachusetts General HospitalAssociate Professor, Harvard Medical SchoolBoston, MassachusettsLink to full program:http://bit.ly/4lOa2kAGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Listen in as Dr Marcus Pereira and Dr Raymund R. Razonable discuss the fundamentals of cytomegalovirus (CMV) in kidney transplant recipients. Topics include: CMV pathogenesisDirect and indirect effects of CMV infection Overview of patient risk factorsCMV risk based on serologic status Presenters:         Marcus Pereira, MD, MPH, FASTAssociate Professor of MedicineDirector of Clinical Services, Division of Infectious DiseasesMedical Director, Transplant Infectious Disease ProgramColumbia University Irving Medical CenterNew York, New YorkRaymund R. Razonable, MD, FIDSA, FASTProfessor of MedicineDivision of Infectious DiseasesMayo Clinic College of Medicine and ScienceRochester, MinnesotaLink to full program:https://bit.ly/41ejruCGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.  

Listen in as Dr Marcus Pereira and Dr Raymund R. Razonable explore strategies for individualization of CMV management in high-risk kidney transplant recipients. Topics include: Risk factors and prevention of late-onset CMV diseaseEarly detection of late CMV infectionCMV cell-mediated immunity monitoringPrimary and secondary prophylaxis Presenters:         Marcus Pereira, MD, MPH, FASTAssociate Professor of MedicineDirector of Clinical Services, Division of Infectious DiseasesMedical Director, Transplant Infectious Disease ProgramColumbia University Irving Medical CenterNew York, New YorkRaymund R. Razonable, MD, FIDSA, FASTProfessor of MedicineDivision of Infectious DiseasesMayo Clinic College of Medicine and ScienceRochester, MinnesotaLink to full program:https://bit.ly/41ejruCGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.  

Anna Person, MD, FIDSA, discusses the role of street medicine in improving access to HIV services and opportunities to support SM programs under Medicaid with Nathan Nolan, MD, MPH, MPHE, Founder of Street Medicine STL and Chris Menschner, Director, Complex Care Programs at the Center for Health Care Strategies.Shape the future of ID with peers from around the world this October at IDWeek in Atlanta, Georgia! Register today ➡️ https://registration.experientevent.com/ShowIDS251View the interactive program ➡️ https://idweek2025.eventscribe.net/

Listen in as Michael Satlin, MD, MS, FIDSA,explores rapid syndromic testing for bloodstream infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing.Topics covered include:Types of upper and lower respiratory infection panelsConsiderations for when to use respiratory syndromic testingHow to use syndromic testing to guide both therapy escalation and de-escalationHow syndromic testing fits in with traditional testing methods, such as culture, antimicrobial susceptibility testing, Gram stain, and BAL cell count Presenter:Michael Satlin, MD, MS, FIDSAAssociate Professor of Medicine and Pathology and Laboratory MedicineWeill Cornell MedicineNew York, New YorkLink to full program: https://bit.ly/3UAB1oUGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Bruce Gellin, MD, MPH, FIDSA, ID physician and senior advisor at the Georgetown University Global Health Institute, joins Buddy Creech, MD, MPH, FPIDS, to discuss the Vaccine Integrity Project and the importance of ensuring vaccine policy remains grounded in evidence. The two explore strategies for countering misinformation, building public trust, and empowering health care professionals to engage in constructive conversations about immunization.Shape the future of ID with peers from around the world this October at IDWeek in Atlanta, Georgia! Register today ➡️ https://registration.experientevent.com/ShowIDS251View the interactive program ➡️ https://idweek2025.eventscribe.net/

July 22, 2025 - In this meeting, the Bipartisan Commission on Biodefense explores: (1) core requirements for effective national biodefense; (2) Administration biodefense priorities; (3) impacts of department and agency realignment; and (4) strategies for addressing future biological threats.   Speakers include: Michael Place, MD (Major General, US Army – Retired) – Former Chief of Staff, Office of the Surgeon General, US Army Command, US Army Erica Pan, MD, MPH – Director and State Public Health Officer, California Department of Public Health Alex Hamberg, VMD, PhD – State Veterinarian, Pennsylvania Department of Agriculture Clint Osborn – Director, District of Columbia Homeland Security and Emergency Management Agency Lori Tremmel Freeman, MBA – Chief Executive Officer, National Association of County and City Health Officials Tina Tan, MD, FIDSA, FPIDS, FAAP – President, Infectious Disease Society of America Ali S. Khan, MD, MPH – Dean, College of Public Health, University of Nebraska Medical Center Richard J. Hatchett, MD – Chief Executive Officer, Coalition for Epidemic Preparedness Innovations Matthew Hepburn, MD – Executive Vice President, Research and Development, Panther Life Sciences Leonard J. Marcus, PhD – Co-Director, National Preparedness Leadership Initiative, Harvard University Taylor Sexton, MPH – Executive Director, Medical Countermeasures Coalition David Stiefel, MA – Director, Global Biological Policy and Programs, Nuclear Threat Initiative Joe Buccina, MA, MS– Policy and Research Director, National Security Commission on Emerging Biotechnology Patricia R. Bright, DVM – Former Senior Science Advisor, One Health/Global Health Security, US Geological Survey Learn more here: https://biodefensecommission.org/events/biodefense-in-crisis-danger-and-opportunity/  

Want to elevate your infection prevention career? Dive into this inspiring episode with Gail Fraine and Dr. Mayar Al Mohajer as they explore the value, purpose, and impact of the Advanced Leadership Certification in Infection Prevention (AL-CIP). Learn how this credential empowers professionals to lead change, drive outcomes, and shape healthcare policy. Get tips for submission success and hear firsthand experiences from these certified leaders! Hosted by: Kelly Holmes, MS, CIC, FAPIC and Lerenza L. Howard, MHA, CIC, LSSGB About our Guests: Gail Fraine, CIC, LTC-CIP, AL-CIP Gail Fraine is the System Director of Infection Prevention at Ascension Saint Thomas in Nashville, TN, with over 30 years of experience reducing healthcare-associated infections through evidence-based practices and high-reliability principles. A long-standing APIC member, she has held national leadership roles including Board Director and Annual Conference Chair. Gail currently serves as President-Elect of the Certification Board of Infection Control and Epidemiology (CBIC) and contributed to developing both the long-term care and Advanced Leadership certifications. She holds nursing degrees from Arkansas State, Belmont, and Vanderbilt, and is certified in CIC, LTC-CIP, and AL-CIP. Mayar Al Mohajer, FIDSA, FSHEA, FAPIC, FACHE, AL-CIP Dr. Al Mohajer serves as Professor of Medicine in the Section of Infectious Diseases at Baylor College of Medicine in Houston, Texas, where he also directs the Infection Prevention, Antimicrobial Stewardship, Quality Improvement, and Leadership Track. He is the Chief of the Infectious Disease Section at Baylor St. Luke's Medical Center and the Medical Director of Infection Prevention, Occupational Health, Diagnostic Stewardship, and Antibiotic Stewardship for CommonSpirit Health's South Region and Baylor St. Luke's Medical Center. In addition to his clinical and academic roles, Dr. Al Mohajer sits on the CBIC Board and co-chairs the National Infection Prevention Council for CommonSpirit Health. He holds multiple fellowships and certifications recognizing his expertise and leadership, including FIDSA, FSHEA, FAPIC, FACHE, and AL-CIP.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JBU865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until June 12, 2026.Unlocking the Potential of Long-Acting PrEP to Halt HIV Transmissions In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JBU865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until June 12, 2026.Unlocking the Potential of Long-Acting PrEP to Halt HIV Transmissions In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JBU865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until June 12, 2026.Unlocking the Potential of Long-Acting PrEP to Halt HIV Transmissions In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JBU865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until June 12, 2026.Unlocking the Potential of Long-Acting PrEP to Halt HIV Transmissions In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

Judy Guzman-Cottrill, DO, Professor of Pediatrics at Oregon Health & Science University, and John Brooks, MD, former CDC medical officer, rejoin Mati Hlatshwayo Davis, MD, MPH, FIDSA, to discuss the impact of federal funding cuts, including the return of preventable diseases, the loss of mental health resources, and what can be done to protect the progress made toward health equity.The IDSA Leadership Institute empowers infectious diseases and HIV practitioners to be future leaders. Crafted specifically by and for specialists in infectious diseases and HIV, the Leadership Institute offers two tailored leadership development pathways.Learn More

Send us a textAs viral diseases both new and old ravage countries across the world, does the growing distrust of physicians, and the healthcare industry at large, have a more profound effect on treatment than most realize?In this episode of CareTalk, Dr. Tyler Evans (CEO & Co-Founder, Wellness and Equity Alliance) joins hosts, John Driscoll and David E. Williams, to discuss the issue of healthcare inequality facing marginalized people groups across the globe, the impact a grassroots connection to a local community can have on the distribution of life-saving medicines, and the struggle to win back trust in a sea of conflicting ideology.

     Join us on this enlightening journey with Retired Army Colonel Joshua D. Hartzel, MD, MS-HPEd, FACP, FIDSA,as we explore his remarkable path in military medicine. Dr. Hartzell shares his early passion for military history, which inspired his decision to join the service through the ROTC program to fund his college education. Discover how influential mentors and the unique opportunities available to infectious disease specialists in the military shaped his specialization in internal medicine and infectious diseases. This episode emphasizes the critical role of leadership development, compassionate care, and effective collaboration in resource-constrained environments.     Dr. Hartzell discusses his deployment experiences, including a transformative time at a military base in Afghanistan. The conversation sheds light on the importance of collaboration among different military units and allied partners, and how these experiences fueled Dr. Hartzell's commitment to developing leaders in military medicine. He discusses his focus on leadership during his time at Walter Reed National Military Medical Center and his book, "A Prescription for Caring in Healthcare Leadership," aimed at guiding healthcare leaders through unique challenges. Dr. Hartzell's stories underscore the significance of setting high standards and providing feedback as essential components of effective leadership.     This episode also explores key leadership themes, such as resource management, role modeling, and building a compassionate culture in healthcare. Learn about the necessity for leaders to manage frustrations, empower their teams, and remain adaptable in challenging circumstances. Dr. Hartzell shares insights from notable and proven leaders, emphasizing the importance of continuous learning and growth in leadership. Whether you're a junior clinician or a seasoned leader, this episode offers valuable insights and practical guidance for enhancing leadership skills and preparing for the unique challenges faced in both military and civilian healthcare settings.   Chapters: (00:03) Military Medicine Journey and Leadership Insights (09:03) Leadership Lessons in Military Medicine (20:28) Resource Management and Leadership Development (23:55) Role Modeling in Leadership Development (32:13) Building a Compassionate Culture in Healthcare (43:05) Delegating With Compassion and Support (50:11) Effective Leadership and Feedback in Medicine   Chapter Summaries: (00:03) Military Medicine Journey and Leadership Insights Dr. Hartzell's journey in military medicine highlights leadership, compassionate care, and mentorship in addressing infections in various environments.   (09:03) Leadership Lessons in Military Medicine Collaboration and leadership in military medicine, shaped by experiences in Iraq and Afghanistan, led to a book on healthcare leadership.   (20:28) Resource Management and Leadership Development Leaders in healthcare must manage frustrations, communicate honestly, delegate effectively, and remain adaptable and optimistic in challenging circumstances.   (23:55) Role Modeling in Leadership Development Leadership development, compassionate leadership, high expectations, tough love, and being a standard bearer.   (32:13) Building a Compassionate Culture in Healthcare Military medicine offers lessons for civilian healthcare, emphasizing leadership, team care, feedback, motivation, and active listening.   (43:05) Delegating With Compassion and Support Empowerment through delegation in leadership, with real-world examples and the decision tree framework, and the importance of compassionate support.   (50:11) Effective Leadership and Feedback in Medicine Feedback and leadership growth are crucial in military medicine, as shown through personal anecdotes and advice for young individuals.   Take Home Messages: Embrace Compassionate Leadership: The episode underscores the importance of compassionate leadership in military medicine. It highlights how setting high expectations, providing support, and offering honest feedback can foster a culture of excellence and empathy, benefiting both leaders and their teams. Value of Mentorship and Collaboration: A recurring theme is the critical role of mentorship and collaboration in professional development. Effective leaders are often shaped by impactful mentors, and successful outcomes in military medicine often stem from seamless collaboration among various units and allied partners. Leadership Challenges Over Clinical Ones: The episode reveals that many challenges in military healthcare are leadership-related rather than clinical. Addressing these leadership challenges is crucial for developing effective leaders who can navigate resource constraints and complex environments. Continuous Leadership Development: Investing time in leadership development is vital for growth. Leaders are encouraged to dedicate time weekly to study leadership through books, podcasts, or conversations with experienced leaders, enhancing their skills and preparing for future challenges. Building a Compassionate Healthcare Culture: Lessons from military medicine can be applied to civilian healthcare, particularly in fostering a compassionate culture. Emphasizing autonomy, mastery, and purpose as motivators, along with active listening and humility, can significantly improve team morale and patient care. Episode Keywords: Military medicine, compassionate leadership, Dr. Joshua D. Hartzell, healthcare leadership, infectious diseases, Walter Reed National Military Medical Center, resource management, leadership development, military healthcare challenges, collaboration in military, mentorship in medicine, setting high standards, feedback in leadership, Army medicine, veteran healthcare insights, podcast episode, healthcare culture   Hashtags: #MilitaryMedicine #CompassionateLeadership #DrJoshuaHartzell #HealthcareLeadership #InfectiousDiseases #WalterReed #LeadershipDevelopment #ResourceManagement #EmpathyInHealthcare #MilitaryHealthcare   Honoring the Legacy and Preserving the History of Military Medicine The WarDocs Mission is to honor the legacy, preserve the oral history, and showcase career opportunities, unique expeditionary experiences, and achievements of Military Medicine. We foster patriotism and pride in Who we are, What we do, and, most importantly, How we serve Our Patients, the DoD, and Our Nation. Find out more and join Team WarDocs at https://www.wardocspodcast.com/ Check our list of previous guest episodes at https://www.wardocspodcast.com/our-guests Subscribe and Like our Videos on our YouTube Channel: https://www.youtube.com/@wardocspodcast Listen to the “What We Are For” Episode 47. https://bit.ly/3r87Afm WarDocs- The Military Medicine Podcast is a Non-Profit, Tax-exempt-501(c)(3) Veteran Run Organization run by volunteers. All donations are tax-deductible and go to honoring and preserving the history, experiences, successes, and lessons learned in Military Medicine. A tax receipt will be sent to you. WARDOCS documents the experiences, contributions, and innovations of all military medicine Services, ranks, and Corps who are affectionately called "Docs" as a sign of respect, trust, and confidence on and off the battlefield,demonstrating dedication to the medical care of fellow comrades in arms.     Follow Us on Social Media Twitter: @wardocspodcast Facebook: WarDocs Podcast Instagram: @wardocspodcast LinkedIn: WarDocs-The Military Medicine Podcast YouTube Channel: https://www.youtube.com/@wardocspodcast    

In this two-part series, Judy Guzman-Cottrill, DO, Professor of Pediatrics, Division of Infectious Diseases at Oregon Health and Science University, and John Brooks, MD,  former CDC medical officer and epidemiologist, join Mati Hlatshwayo Davis, MD, MPH, FIDSA, to discuss the real-time consequences of federal funding cuts on public health. From dismantled community partnerships to stalled clinical trials, the three examine how these decisions are reshaping pandemic preparedness, and what we risk losing next.The IDSA Leadership Institute empowers infectious diseases and HIV practitioners to be future leaders. Crafted specifically by and for specialists in infectious diseases and HIV, the Leadership Institute offers two tailored leadership development pathways.Learn More

ID physicians Priya Nori, MD, FSHEA, FIDSA, and Gonzalo Bearman, MD, MPH, FACP, FSHEA, FIDSA, join Paul Sax, MD, FIDSA, to discuss challenges often faced by ID specialists, including gaslighting and uncompensated labor. The three discuss how physicians can advocate for themselves, set boundaries, and push for meaningful change within their institutions.Are We Being Gaslit? A Primer for Recognizing Corporate Jargon to Overcome Gaslighting for the Infectious Disease Workforce: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciaf097/8056053Minimizing Low-Value, Uncompensated Work in Academic Infectious Diseases: A 6-Step Program: https://academic.oup.com/cid/article/78/6/1656/7610959

We've all heard of medical malpractice and its dire costs, but what about leadership malpractice? Should there be consequences or at least more resistance to those implementing non-evidence-based leadership tactics in academic medicine? Those questions and much more are explored in depth with our guest this week on the Faculty Factory Podcast, author Joshua Hartzell, MD, MS-HPEd, FACP, FIDSA, who joins us to discuss: Leadership responsibility and development Cultural strategies from the military that could be woven into academic health Excellence through empathy and compassion Utilizing delegation as a growth opportunity for others With 25 years in military medicine under his belt, Dr. Hartzell is a retired army colonel and a practicing internal medicine and infectious diseases physician. It's all about being more intentional with how we lead and taking care of people—that is what a healthy workplace culture rides on, according to this interview with Dr. Hartzell. "Most of the things we experience and our challenges are not clinical care issues. It's a leadership issue. We're really good at the clinical care part, but not so much the messy leadership stuff and how to deal with that," he said. Learn More Explore his book, "A Prescription for Caring in Healthcare Leadership: Building a Culture of Compassion and Excellence": https://www.amazon.com/Prescription-Caring-Healthcare-Leadership-Compassion/dp/B0DSQ4276K Visit Faculty Factory: https://facultyfactory.org/ 

Paul Sax, MD, FIDSA, is joined by infectious diseases physicians and international medical graduates, Vidya Sundareshan, MD, and Alfredo Mena Lora, MD, FIDSA, to discuss how international medical graduates (IMGs) can pursue a career in infectious diseases. The trio discuss visa options, job search strategies, and how political change could impact the process.

Paul Sax, MD, FIDSA, speaks with Adam Ratner, MD, MPH, Professor of Pediatrics and Microbiology at NYU Grossman School of Medicine and Director of the Division of Pediatric Infectious Diseases at Hassenfeld Children's Hospital and Bellevue Hospital Center, about his book, "Booster Shots: The Urgent Lessons of Measles" and the rise of vaccine preventable diseases.